IL-24 sensitizes tumor cells to TLR3-mediated apoptosis

Cell Death and Differentiation

Volumn 20, Issue 6, 2013, Pages 823-833

  Weiss, R ^a   Sachet, M ^a   Zinngrebe, J ^b   Aschacher, T ^a   Krainer, M ^a   Hegedus, B ^a,c   Walczak, H ^a   Bergmann, M ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

cancer; IL 24; oncolytic influenza virus; TLR3

Indexed keywords

CASPASE 8; ENZYME INHIBITOR; INTERLEUKIN 24; TOLL LIKE RECEPTOR 3; VIRUS VECTOR;

APOPTOSIS; ARTICLE; CANCER CELL; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLUENZA VIRUS A; PRIORITY JOURNAL; SENSITIZATION; TUMOR CELL; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; CASPASE 8; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CYTOKINES; ENZYME ACTIVATION; HUMANS; INFLUENZA A VIRUS; INTERLEUKINS; MALE; MELANOMA; NEOPLASMS; ONCOLYTIC VIROTHERAPY; PROSTATIC NEOPLASMS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TOLL-LIKE RECEPTOR 3; TRANSGENES; UP-REGULATION;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 84877580504     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.15     Document Type: Article

References (51)

1. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995; 11: 2477-2486.
2. Jiang H, Su ZZ, Lin JJ, Goldstein NI, Young CS, Fisher PB. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc Natl Acad Sci USA. 1996; 93: 9160-9165.
3. Eager R, Harle L, Nemunaitis J. Ad-MDA-7; INGN 241: a review of preclinical and clinical experience. Expert Opin Biol Ther 2008; 8: 1633-1643.
4. Cunningham CC, Chada S, Merritt JA, Tong A, Senzer N, Zhang Y et al. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol Ther 2005; 11: 149-159.
5. Jiang G, Zhang L, Xin Y, Pei DS, Wei ZP, Liu YQ et al. Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy. Acta Oncol 2012; 51: 285-292.
6. Pataer A, Vorburger SA, Barber GN, Chada S, Mhashilkar AM, Zou-Yang H et al. Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res 2002; 62: 2239-2243.
7. Sarkar D, Su ZZ, Lebedeva IV, Sauane M, Gopalkrishnan RV, Valerie K et al. mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci USA. 2002; 99: 10054-10059.
8. Yacoub A, Mitchell C, Lebedeva IV, Sarkar D, Su ZZ, McKinstry R et al. mda-7 (IL-24) inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling. Cancer Biol Ther 2003; 2: 347-353.
9. Dash R, Richards JE, Su ZZ, Bhutia SK, Azab B, Rahmani M et al. Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokine. Cancer Res 2010; 70: 5034-5045.
10. Lebedeva IV, Sarkar D, Su ZZ, Kitada S, Dent P, Stein CA et al. Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24. Oncogene 2003; 22: 8758-8773.
11. Fisher PB, Sarkar D, Lebedeva IV, Emdad L, Gupta P, Sauane M et al. Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma. Toxicol Appl Pharmacol 2007; 224: 300-307.
12. Dash R, Bhutia SK, Azab B, Su ZZ, Quinn BA, Kegelmen TP et al. mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity. Cytokine Growth Factor Rev 2010; 21: 381-391.
13. Tamai H, Miyake K, Yamaguchi H, Takatori M, Dan K, Inokuchi K et al. AAV8 vector expressing IL24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL/AF4-positive ALL model mice. Blood 2012; 119: 64-71.
14. Chada S, Bocangel D, Ramesh R, Grimm EA, Mumm JB, Mhashilkar AM et al. mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer. Mol Ther 2005; 11: 724-733.
15. Chada S, Mhashilkar AM, Ramesh R, Mumm JB, Sutton RB, Bocangel D et al. Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptordependent but STAT3-independent mechanism. Mol Ther 2004; 10: 1085-1095.
16. Zheng M, Bocangel D, Doneske B, Mhashilkar A, Ramesh R, Hunt KK et al. Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10. Cancer Immunol Immunother 2007; 56: 205-215.
17. Sauane M, Gopalkrishnan RV, Choo HT, Gupta P, Lebedeva IV, Yacoub A et al. Mechanistic aspects of mda-7/IL-24 cancer cell selectivity analysed via a bacterial fusion protein. Oncogene 2004; 23: 7679-7690.
18. Sauane M, Lebedeva IV, Su ZZ, Choo HT, Randolph A, Valerie K et al. Melanoma differentiation associated gene-7/interleukin-24 promotes tumor cell-specific apoptosis through both secretory and nonsecretory pathways. Cancer Res 2004; 64: 2988-2993.
19. Caudell EG, Mumm JB, Poindexter N, Ekmekcioglu S, Mhashilkar AM, Yang XH et al. The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J Immunol 2002; 168: 6041-6046.
20. Kreis S, Philippidou D, Margue C, Rolvering C, Haan C, Dumoutier L et al. Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells. PLoS One 2007; 2: e1300.
21. Bannerman DD, Eiting KT, Winn RK, Harlan JM. FLICE-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kappaB activation induced by bacterial lipopolysaccharide. Am J Pathol 2004; 165: 1423-1431.
22. Salaun B, Romero P, Lebecque S. Toll-like receptors' two-edged sword: when immunity meets apoptosis. Eur J Immunol 2007; 37: 3311-3318.
23. Weber A, Kirejczyk Z, Besch R, Potthoff S, Leverkus M, Hacker G. Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells. Cell Death Differ 2010; 17: 942-951.
24. Estornes Y, Toscano F, Virard F, Jacquemin G, Pierrot A, Vanbervliet B et al. dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8. Cell Death Differ 2012; 19: 1482-1494.
25. Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011; 43: 449-463.
26. Bergmann M, Romirer I, Sachet M, Fleischhacker R, Garcia-Sastre A, Palese P et al. A genetically engineered influenza A virus with ras-dependent oncolytic properties. Cancer Res 2001; 61: 8188-8193.
27. Egorov A, Brandt S, Sereinig S, Romanova J, Ferko B, Katinger D et al. Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J Virol 1998; 72: 6437-6441.
28. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 1998; 252: 324-330.
29. Wolschek M, Samm E, Seper H, Sturlan S, Kuznetsova I, Schwager C et al. Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency. J Virol 2011; 85: 2469-2473.
30. Zhirnov OP, Konakova TE, Wolff T, Klenk HD. NS1 protein of influenza A virus downregulates apoptosis. J Virol 2002; 76: 1617-1625.
31. Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M et al. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 2007; 178: 3368-3372.
32. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M et al. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 2005; 280: 5571-5580.
33. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303: 1529-1531.
34. Ramos I, Fernandez-Sesma A. Cell receptors for influenza a viruses and the innate immune response. Front Microbiol 2012; 3: 117.
35. Vandenabeele P, Vanden Berghe T, Festjens N. Caspase inhibitors promote alternative cell death pathways. Sci STKE 2006; 2006: pe44.
36. Christofferson DE, Yuan J. Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 2010; 22: 263-268.
37. Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 2005; 175: 3339-3346.
38. Lebedeva IV, Su ZZ, Chang Y, Kitada S, Reed JC, Fisher PB. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene 2002; 21: 708-718.
39. Sarkar D, Su ZZ, Park ES, Vozhilla N, Dent P, Curiel DT et al. A cancer terminator virus eradicates both primary and distant human melanomas. Cancer Gene Ther 2008; 15: 293-302.
40. Su ZZ, Lebedeva IV, Sarkar D, Emdad L, Gupta P, Kitada S et al. Ionizing radiation enhances therapeutic activity of mda-7/IL-24: overcoming radiation-and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2. Oncogene 2006; 25: 2339-2348.
41. Sauane M, Su ZZ, Gupta P, Lebedeva IV, Dent P, Sarkar D et al. Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis. Proc Natl Acad Sci USA. 2008; 105: 9763-9768.
42. Sauane M, Su ZZ, Dash R, Liu X, Norris JS, Sarkar D et al. Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis. J Cell Physiol 2010; 222: 546-555.
43. Sieger KA, Mhashilkar AM, Stewart A, Sutton RB, Strube RW, Chen SY et al. The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells. Mol Ther 2004; 9: 355-367.
44. Appledorn DM, Patial S, McBride A, Godbehere S, Van Rooijen N, Parameswaran N et al. Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J Immunol 2008; 181: 2134-2144.
45. Laredj LN, Beard P. Adeno-associated virus activates an innate immune response in normal human cells but not in osteosarcoma cells. J Virol 2011; 85: 13133-13143.
46. Hosel M, Broxtermann M, Janicki H, Esser K, Arzberger S, Hartmann P et al. Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors. Hepatology 2012; 55: 287-297.
47. Lehner M, Kellert B, Proff J, Schmid MA, Diessenbacher P, Ensser A et al. Autocrine TNF is critical for the survival of human dendritic cells by regulating BAK, BCL-2, and FLIPL. J Immunol 2012; 188: 4810-4818.
48. Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T. TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 2006; 176: 4894-4901.
49. Walczak H. TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer. Immunol Rev 2011; 244: 9-28.
50. Wacheck V, Egorov A, Groiss F, Pfeiffer A, Fuereder T, Hoeflmayer D et al. A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1. J Infect Dis 2010; 201: 354-362.
51. Lopez J, Poitevin A, Mendoza-Martinez V, Perez-Plasencia C, Garcia-Carranca A. Cancerinitiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer 2012; 12: 48.